HKBU receives HK$1 million donation from Thomas H.C. Cheung Foundation Limited
HKBU recently received a generous donation of HK$1 million from Thomas H.C. Cheung Foundation Limited (the Foundation) in support of the University’s Chinese medicine research on breast cancer.
The Foundation was established by Dr. Cheung Huen Cheong Thomas, MH, FCII, in 1992 to support both local and overseas charitable causes in education, healthcare and poverty. Dr. Cheung is a prominent figure in the insurance industry in Hong Kong, with over 70 years of experience. He is the Chairman of The Pacific Insurance Co., Ltd. and The Pacific Life Assurance Co., Ltd. In recognition of his distinguished service and contributions to the insurance profession, Dr. Cheung was named an Honorary Fellow by the Chartered Insurance Institute in 2019, which made him the first international insurance professional from outside the United Kingdom to receive the honour. He also served as an Honorary Consul for Sri Lanka in Hong Kong and Macau SAR for nearly 30 years, and was also awarded the National Honour Sri Lanka Ranjana by the President of Sri Lanka in 1991.
Believing that knowledge can change fate, Dr. Cheung has been a passionate advocate for education, having served as Honorary Chairman or Director of a number of educational institutions. His contributions to education had earned him a Doctor of Laws, honoris causa, and an Honorary Fellow from The Chinese University of Hong Kong, and an Honorary University Fellow from the Open University of Hong Kong.
Professor Bian Zhaoxiang, Associate Vice-President (Chinese Medicine Development), expressed his heartfelt gratitude to the Foundation for its ardent support. He said, “Breast cancer is one of the most common and deadliest cancers among women in Hong Kong. HKBU has been conducting research on the use of Chinese herbal medicine with nano-carrier to enhance the efficacy of anti-cancer treatment over the years. We believe Dr. Cheung’s generous donation will certainly help to further enhance the research capacity of the School of Chinese Medicine in the treatment of breast cancer through Chinese medicine.”.